Novel Risk Factors for Atrial Fibrillation: Useful for Risk Prediction and Clinical Decision Making?

Atrial fibrillation (AF) is the most common cardiac arrhythmia; the lifetime risk is 1 in 4 for persons over the age of 40 years in the United States.1 AF is associated with an increased risk of death, dementia, heart failure, and stroke.2–5 AF leads to high healthcare system utilization rates.6 Based on current US age- and sex-specific prevalence data, the national incremental AF cost in 2010 is estimated to range from $6.0 to $26.0 billion.7 Risk factors for AF are diverse8 and include advancing age, male sex, diabetes mellitus, hypertension, valvular disease, myocardial infarction, heart failure, obesity, elevated inflammatory marker concentrations, and PR-interval prolongation, as recently reviewed elsewhere.9 Risk prediction models are important to define individual risk for AF, to identify novel risk factors for AF, to identify and assess potential targets of therapy, and to enhance the cost-effective implementation of therapies for both primary and secondary prevention of AF.10 A recently published risk score for the development of AF based on the established cardiovascular risk factors accounted for only part of the AF risk (C-statistic 0.76).11 Thus, although many risk factors for AF have been described, a substantial proportion of AF risk still remains unexplained. In the past years, multiple novel AF risk factors have been studied. In the present review, we aim to describe recently described risk factors and will underscore that substantial efforts are needed to incorporate novel markers of AF into risk prediction models. Efforts to optimize risk prediction models and prevention algorithms are useful for risk communication, patient motivation, and clinical decision making.10 ### Familial Aggregation In recent years, increasing data have been reported supporting the notion that AF in the general population is heritable. Diverse population-based studies have demonstrated that familial clustering of AF is common. …

[1]  A. Sharrett,et al.  Blood Lipid Levels, Lipid-Lowering Medications, and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study , 2012, Circulation. Arrhythmia and electrophysiology.

[2]  Thomas Meitinger,et al.  Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.

[3]  Thomas Meitinger,et al.  Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. , 2008, European heart journal.

[4]  David D. McManus,et al.  Atrial Fibrillation Atrial Fibrillation Current Knowledge and Future Directions in Epidemiology and Genomics , 2011 .

[5]  Zhao Zhang,et al.  Ablation of a Ca2+‐activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation , 2009, The Journal of physiology.

[6]  Randy L. Johnson,et al.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification , 2010, Proceedings of the National Academy of Sciences.

[7]  Udo Hoffmann,et al.  Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study , 2010, Circulation. Arrhythmia and electrophysiology.

[8]  Richard P. Harvey,et al.  Molecular Pathway for the Localized Formation of the Sinoatrial Node , 2007, Circulation research.

[9]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[10]  I-Min Lee,et al.  Physical Activity and the Risk of Incident Atrial Fibrillation in Women , 2008, Circulation. Cardiovascular quality and outcomes.

[11]  Debbie A Lawlor,et al.  Birth weight and risk of type 2 diabetes: a systematic review. , 2008, JAMA.

[12]  B. Gersh Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study , 2012 .

[13]  Daniel Levy,et al.  Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute , 2009, Circulation.

[14]  Frank M. Sacks,et al.  Association of Plasma Phospholipid Long-Chain Omega-3 Fatty Acids With Incident Atrial Fibrillation in Older Adults: The Cardiovascular Health Study , 2012, Circulation.

[15]  Leif Hove-Madsen,et al.  PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis , 2011, Circulation. Cardiovascular genetics.

[16]  Oliver Gaemperli,et al.  Prevalence of Coronary Artery Disease Assessed by Multislice Computed Tomography Coronary Angiography in Patients With Paroxysmal or Persistent Atrial Fibrillation , 2009, Circulation. Cardiovascular imaging.

[17]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[18]  Nancy R Cook,et al.  Birth weight is a significant risk factor for incident atrial fibrillation. , 2010, Circulation.

[19]  Michael Jerosch-Herold,et al.  American Heart Association Atrial Fibrillation Research Summit: A Conference Report From the American Heart Association , 2011, Circulation.

[20]  Ulrich Schotten,et al.  PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression , 2011, Circulation. Cardiovascular genetics.

[21]  Ralph B D'Agostino,et al.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.

[22]  D. Lloyd‐Jones,et al.  Cardiovascular risk prediction: basic concepts, current status, and future directions. , 2010, Circulation.

[23]  Eric Boerwinkle,et al.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.

[24]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[25]  James B Seward,et al.  Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. , 2008, The American journal of cardiology.

[26]  Thomas Meitinger,et al.  Lack of replication in polymorphisms reported to be associated with atrial fibrillation. , 2011, Heart rhythm.

[27]  Walter C Willett,et al.  Exercise type and intensity in relation to coronary heart disease in men. , 2002, JAMA.

[28]  Johan P Mackenbach,et al.  Health disadvantage in US adults aged 50 to 74 years: a comparison of the health of rich and poor Americans with that of Europeans. , 2009, American journal of public health.

[29]  Elsayed Z Soliman,et al.  Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2011, Circulation. Arrhythmia and electrophysiology.

[30]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[31]  Richard A. Kronmal,et al.  N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study , 2009, Circulation.

[32]  P. Ellinor,et al.  Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[33]  Lesley H. Curtis,et al.  Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007 , 2012, Circulation. Cardiovascular quality and outcomes.

[34]  Sunil K. Agarwal,et al.  Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.

[35]  Daniel Levy,et al.  Doppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study). , 2003, The American journal of cardiology.

[36]  Yi Zhang,et al.  Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts* , 2003, Journal of Biological Chemistry.

[37]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[38]  Jesper Hastrup Svendsen,et al.  Familial Aggregation of Atrial Fibrillation: A Study in Danish Twins , 2009, Circulation. Arrhythmia and electrophysiology.

[39]  M. J. Banks M. Glymour and J. Mackenback Avendano Health disadvantage in US adults aged 50-74: Are poor Europeans healthier than wealth Americans? , 2009 .

[40]  D. Levy,et al.  Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community , 2010, Circulation.

[41]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[42]  D. Hodge,et al.  The natural history of preclinical diastolic dysfunction: a population-based study. , 2010, Circulation. Heart failure.

[43]  Richard P Harvey,et al.  Pitx2c and Nkx2-5 Are Required for the Formation and Identity of the Pulmonary Myocardium , 2007, Circulation research.

[44]  Michael J Pencina,et al.  Validation of an atrial fibrillation risk algorithm in whites and African Americans. , 2010, Archives of internal medicine.

[45]  Eric Boerwinkle,et al.  Independent Susceptibility Markers for Atrial Fibrillation on Chromosome 4q25 , 2010, Circulation.

[46]  Robert J. Glynn,et al.  Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women , 2009, Circulation.

[47]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[48]  Thomas Jespersen,et al.  Inhibition of Small-Conductance Ca2+-Activated K+ Channels Terminates and Protects Against Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[49]  Paul Schoenhagen,et al.  Left Atrial Epicardial Adiposity and Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[50]  Josef Coresh,et al.  Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.

[51]  M. Murphy,et al.  The effect of walking on fitness, fatness and resting blood pressure: a meta-analysis of randomised, controlled trials. , 2007, Preventive medicine.

[52]  Curt D. Furberg,et al.  Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study , 2008, Circulation.

[53]  Michael A Rosenberg,et al.  Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. , 2012, European heart journal.

[54]  Lewis E Kazis,et al.  Racial differences in the prevalence of atrial fibrillation among males. , 2008, Journal of the National Medical Association.

[55]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[56]  H. Sacks,et al.  Human epicardial adipose tissue: a review. , 2007, American heart journal.

[57]  G. Breithardt,et al.  Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[58]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[59]  Nancy R Cook,et al.  Relation of vigorous exercise to risk of atrial fibrillation. , 2009, The American journal of cardiology.

[60]  Sudha Seshadri,et al.  Large-Scale Candidate Gene Analysis in Whites and African Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation: The National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) Project , 2011, Circulation. Cardiovascular genetics.

[61]  Kathleen F. Kerr,et al.  European Ancestry as a Risk Factor for Atrial Fibrillation in African Americans , 2010, Circulation.

[62]  Michael J Pencina,et al.  Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. , 2010, JAMA.